Immune Clearance of Senescent Cells

Senescent cells are not only formed; they are also surveilled and removed. Immune-mediated clearance is considered a key determinant of whether senescence remains transient or accumulates over time. This process involves innate and adaptive immune mechanisms and varies by tissue context. [1] [2] [3]

How Immune Recognition Occurs

Senescent cells can display altered surface ligands and secrete factors that recruit immune cells, including NK cells, macrophages, and T cells. Experimental work shows that this signaling can support surveillance and elimination, particularly when senescence is acute. [1] [4] [5]

Why Clearance Can Decline with Age

Age-associated immune remodeling (often discussed alongside immunosenescence and chronic inflammation) may reduce clearance efficiency. When formation rates exceed removal rates, senescent cell burden can rise across tissues. Human data support association patterns, while direct causal quantification remains limited. [2] [6] [7]

Cancer and Fibrosis Contexts

In liver and fibrosis models, immune-dependent clearance of senescent cells has been linked to better tissue outcomes. In tumor settings, immune surveillance of senescence can contribute to suppression, but effects differ by microenvironment and disease stage. [4] [8] [9]

Current Limits and Uncertainty

• Most mechanistic evidence comes from animal and ex vivo systems rather than direct human tissue tracking. [3] [7]
• Immune cell subsets involved in clearance vary by organ and trigger, limiting universal models. [1] [5]
• It is unresolved how much accumulation reflects increased senescence formation vs reduced clearance across different ages and diseases. [2] [10]

Related Reading

• The SASP Explained
• Senescent Cells and Cancer
• What Is Ageing?
• Glossary

Summary

Immune surveillance is central to senescence dynamics: it can constrain senescent cell persistence but appears less efficient under some ageing conditions. Evidence supports this framework, yet important human-specific mechanisms and quantitative rates remain incompletely mapped.

References

1. Ovadya, Y., Krizhanovsky, V. "Strategies targeting cellular senescence." Journal of Clinical Investigation (2018). https://pubmed.ncbi.nlm.nih.gov/29400749/
2. Ovadya, Y. et al. "Impaired immune surveillance accelerates accumulation of senescent cells and aging." Nature Medicine (2018). https://pubmed.ncbi.nlm.nih.gov/30575733/
3. Di Micco, R. et al. "Cellular senescence in ageing: from mechanisms to therapeutic opportunities." Nature Reviews Molecular Cell Biology (2021). https://pubmed.ncbi.nlm.nih.gov/33328614/
4. Krizhanovsky, V. et al. "Senescence of activated stellate cells limits liver fibrosis." Cell (2008). https://pubmed.ncbi.nlm.nih.gov/18724938/
5. Sagiv, A. et al. "Granule exocytosis mediates immune surveillance of senescent cells." Oncogene (2013). https://pubmed.ncbi.nlm.nih.gov/23160365/
6. Lopez-Otin, C. et al. "Hallmarks of aging: An expanding universe." Cell (2023). https://pubmed.ncbi.nlm.nih.gov/36599349/
7. Gorgoulis, V. et al. "Cellular Senescence: Defining a Path Forward." Cell (2019). https://doi.org/10.1016/j.cell.2019.10.005
8. Xue, W. et al. "Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas." Nature (2007). https://pubmed.ncbi.nlm.nih.gov/17251933/
9. Kang, T.-W. et al. "Senescence surveillance of pre-malignant hepatocytes limits liver cancer development." Nature (2011). https://pubmed.ncbi.nlm.nih.gov/21430708/
10. Prata, L. G. P. L. et al. "Senescence and Immunity: The role of immune surveillance in clearing senescent cells." Current Opinion in Immunology (2019). https://pubmed.ncbi.nlm.nih.gov/31055120/